Is Pharmaceutical innovation pushing HTA in the UK? The Innovative Medicines Fund, UK
Updated on 30th July 2022 The guidelines for Innovative Medicines Fund (IMF) have been issued by NHS on June 6, 2022. The design of the IMF has been largely drawn on the lines of Cancer Drug Funds (CDF). Along with the guidelines, the responses to engagement on proposals for IMF have been released. This update […]